- Investing Ideas
- /
- Chinese Pharmaceuticals & Biotech High Return On Equity, Low Debt
Chinese Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
2
0 new
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
2 companies
Xiamen Amoytop Biotech
Market Cap: CN¥33.1b
Engages in research, development, production, and sale of recombinant protein drugs in China.
688278
CN¥80.90
7D
-1.2%
1Y
33.7%
Tianjin Pharmaceutical Da Ren Tang Group
Market Cap: CN¥30.2b
Produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People’s Republic of China.
600329
CN¥44.44
7D
-3.6%
1Y
66.1%